Latest news
Pfizer (PFE) Reports Positive Phase 3 LITFULO Data In Vitiligo - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:13:26 GMTPhase III Trials Show Positive Results for Ritlecitinib in Nonsegmental Vitiligo - Medical DialoguesMedical Dialogues · Sun, 02 Aug 2026 23:30:18 GMTPfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings - Indian Pharma PostIndian Pharma Post · Sat, 01 Aug 2026 14:24:34 GMTPfizer's ritlecitinib advances to become first oral systemic therapy for nonsegmental vitiligo - AllSciAllSci · Thu, 30 Jul 2026 16:35:55 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 13:32:39 GMTRitlecitinib Improves Repigmentation in Nonsegmental Vitiligo Phase 3 Data - HCPLiveHCPLive · Thu, 30 Jul 2026 13:27:25 GMTPfizer announces phase 3 results for nonsegmental vitiligo treatment - PMLiVEPMLiVE · Thu, 30 Jul 2026 11:38:37 GMTPfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMT